Endoscopic Submucosal Dissection Using EndoTrac, a Novel Traction Device.
Hidetoshi Kaku1, Takashi Toyonaga2,3, Shinwa Tanaka1
1Divison of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan.
Digestion
|December 22, 2020
Summary
The EndoTrac device offers a feasible and safe approach for endoscopic submucosal dissection (ESD) in gastrointestinal neoplasms. This novel traction method demonstrated high procedural success rates across various GI locations.
Area of Science:
- Gastroenterology
- Endoscopic Surgery
- Medical Device Innovation
Background:
- Endoscopic submucosal dissection (ESD) is a minimally invasive treatment for superficial gastrointestinal (GI) cancers.
- Challenges in ESD include time consumption and adverse events like bleeding and perforation.
- Effective traction methods are crucial for optimal submucosal visualization during ESD.
Purpose of the Study:
- To evaluate the safety and feasibility of the novel EndoTrac device for ESD procedures.
- To assess the performance of EndoTrac in facilitating traction and visualization during GI neoplasm resection.
Main Methods:
- Retrospective analysis of 44 patients (45 lesions) undergoing ESD with the EndoTrac device.
- Procedures included esophageal, gastric, duodenal, and colorectal neoplasms.
- Outcome measures: preparation time, procedural success, and ease of changing towing direction.
Main Results:
- 100% procedural success rates were achieved in the esophagus, stomach, duodenum, and colorectum.
- Mean preparation times varied by location: esophagus (2 min), stomach (3 min), duodenum (6 min), and colorectum (4 min).
- Successful bi-directional (proximal and distal) towing was achieved in 100% of esophageal, gastric, and colorectal cases, with 0% in duodenal cases.
Conclusions:
- The EndoTrac device is a feasible and effective tool for performing ESD in GI neoplasms.
- The device facilitates successful traction and visualization, contributing to high procedural success rates.
